Reeve Emma bought PTCT
October 30, 2025 · Form 4 insider transaction
Reeve Emma bought 12,000 shares of PTC Therapeutics, Inc. at $38.10 per share, a transaction worth $457.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$38.10
Total value
$457.2K
InsiderReeve Emma
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 30, 2025
Filing dateOctober 31, 2025
Shares owned after18,666
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.